|Articles|June 10, 2015 (Updated: April 18, 2020)

Special Reports

  • Precision Medicine
  • Volume 2
  • Issue 1

Significance of the NCI Molecular Analysis for Therapy Choice Program

Jonathan C. Trent, MD, PhD, professor of medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Health System, gives an overview of the NCI Molecular Analysis for Therapy Choice Program (MATCH).

Jonathan C. Trent, MD, PhD, professor of medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Health System, gives an overview of the NCI Molecular Analysis for Therapy Choice Program (MATCH).

<<<

View more from the Precision Medicine Special Report


Latest CME